InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Robinson James A. Jr.. Insider active across 2 companies, notably UroGen Pharma Ltd.. In total, 4 reports have been recorded. Activity tracked since 10 January 2026. The latest transaction was disclosed on 10 January 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Robinson James A. Jr. is a declarant associated with UroGen Pharma Ltd. and Eledon Pharmaceuticals, Inc., where he is a Director. The record includes 4 filings, all in the sampled set, with recent filings ranging from 2025-12-01 to 2026-08-28. The modal transaction nature shown is Option exercise, and the aggregated buy and sell amounts are both 0 euros in the sampled filings.